Novel “RA Response Calculator” Uses AI and Real Patient Data to Help Doctors Better Tailor Treatment Plans WALTHAM, MA – June 18, 2025 – At the European Congress of Rheumatology (EULAR) 2025, Scipher Medicine, the company behind the groundbreaking PrismRA® test,...
WALTHAM, Massachusetts – June 16, 2025 Scipher Medicine, a leading precision immunology company, today announced a strategic alliance with Grupo Amarey, a leading company in the representation and distribution of technologies, solutions, and services for the...
Partnership integrates Scipher’s PrismRA to deliver insights into therapy response segmentation WALTHAM, Mass.–(BUSINESS WIRE)–Scipher Medicine, a precision immunology company dedicated to transforming patient care through data-driven insights, today...
Collaboration combines Scipher’s unique RNAseq data, part of the largest non-oncology clinico-transcriptomic data lake and biobank, with InnoSIGN’s proprietary Comprehensive Pathway Analysis (CPA) platform to enhance the understanding of complex...
The partnership integrates Kythera’s enriched high-fidelity multi-source EHR and claims data assets with real-world clinical and genomic data from Scipher’s PrismRA® Test, revealing new insights for precision medicine advancements. Waltham, MA-April 15, 2025 – Scipher...
Waltham, MA – Jan. 13, 2025 – Scipher Medicine, a leader in precision medicine for autoimmune diseases, and Roivant, a global biopharmaceutical company that aims to improve the lives of patients by accelerating the development and commercialization of medicines that...
